Ventricular arrhythmia in congenital heart diseases with a systemic right ventricle
- PMID: 39712230
- PMCID: PMC11657340
- DOI: 10.1016/j.ijcchd.2023.100463
Ventricular arrhythmia in congenital heart diseases with a systemic right ventricle
Erratum in
-
Erratum regarding missing Disclosure statement in previously published articles.Int J Cardiol Congenit Heart Dis. 2024 Feb 20;15:100498. doi: 10.1016/j.ijcchd.2024.100498. eCollection 2024 Mar. Int J Cardiol Congenit Heart Dis. 2024. PMID: 39713500 Free PMC article.
Abstract
Congenital heart disease (CHD) often involves the systemic right ventricle (SRV), which is the morphological right ventricle that supports systemic circulation. SRV patients are at a higher risk of sudden cardiac death (SCD) than other adult CHD patients and continues to be a significant cause of death in this aging population. However, the pathophysiology of ventricular arrhythmias in SRV is still not fully understood, and there may be differences between subtypes of CHD. Although these events are rare, predicting them is challenging. This review discusses contemporary strategies for assessing and preventing the risk of ventricular arrhythmias in SRV patients. Several risk factors have been identified to be associated with ventricular arrhythmias in patients with SRV. A recent risk stratification model combines independently associated factors into a risk score, and subpulmonary left ventricle dysfunction is emerging as a critical factor in risk assessment. Cardiac magnetic resonance imaging, biomarkers, and genetic data may refine the ability to predict ventricular arrhythmias in SRV. However, the question of whether implantable cardioverter-defibrillators (ICDs) should be used as a preventive measure in this cohort remains unanswered. Multicenter studies are needed to evaluate risk models and ICD use in this aging population. Given that ICDs have drawbacks, such as a high rate of inappropriate shocks and late lead-related complications, shared clinical decision-making is crucial when considering their use. The review emphasizes the need for further research in this area to improve the identification of patients at risk of clinical ventricular arrhythmias and to develop effective prevention strategies.
Keywords: Implantable cardioverter-defibrillator; Sudden cardiac death; Systemic right ventricle; Transposition of the great arteries; Ventricular arrhythmia.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Brida M., Diller G.P., Gatzoulis M.A. Systemic right ventricle in adults with congenital heart disease: anatomic and phenotypic spectrum and current approach to management. Circulation. 2018 30;137(5):508–518. - PubMed
-
- Ladouceur M., Van De Bruaene A., Kauling R., Budts W., Roos-Hesselink J., Albert S.V., et al. A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle. Eur Heart J. 2022 Jul 21;43(28):2685–2694. - PubMed
-
- https://www.ahajournals.org/doi/10.1161/circulationaha.114.010770 Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark | Circulation [Internet]. [cited 2020 Jun 10]. Available from: - DOI
-
- Hoffman J.I.E., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002 Jun 19;39(12):1890–1900. - PubMed
-
- Vejlstrup N., Sørensen K., Mattsson E., Thilén U., Kvidal P., Johansson B., et al. Long-term outcome of mustard/senning correction for transposition of the great arteries in Sweden and Denmark. Circulation. 2015 Aug 25;132(8):633–638. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
